Ashton Thomas Private Wealth LLC acquired a new stake in STERIS plc (NYSE:STE - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,557 shares of the medical equipment provider's stock, valued at approximately $320,000.
Other hedge funds also recently modified their holdings of the company. Geode Capital Management LLC lifted its position in STERIS by 0.7% in the third quarter. Geode Capital Management LLC now owns 2,303,625 shares of the medical equipment provider's stock worth $556,786,000 after purchasing an additional 17,007 shares during the period. Principal Financial Group Inc. lifted its position in STERIS by 0.5% in the fourth quarter. Principal Financial Group Inc. now owns 1,119,643 shares of the medical equipment provider's stock worth $230,160,000 after purchasing an additional 5,419 shares during the period. Raymond James Financial Inc. bought a new position in STERIS in the fourth quarter worth $223,987,000. Franklin Resources Inc. lifted its position in STERIS by 171.2% in the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock worth $191,370,000 after purchasing an additional 529,308 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in STERIS by 3.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 569,837 shares of the medical equipment provider's stock worth $117,136,000 after purchasing an additional 18,384 shares during the period. 94.69% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several research analysts recently commented on STE shares. Stephens reaffirmed an "overweight" rating and issued a $240.00 target price on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler raised their target price on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. Finally, JMP Securities reissued a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a report on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $258.75.
Get Our Latest Research Report on STE
STERIS Stock Down 1.5 %
Shares of NYSE STE opened at $228.13 on Wednesday. The stock has a market cap of $22.41 billion, a PE ratio of 48.44 and a beta of 0.92. The business has a fifty day moving average of $217.94 and a two-hundred day moving average of $222.62. STERIS plc has a 52-week low of $197.82 and a 52-week high of $248.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13.
STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, equities research analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.
STERIS Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be paid a $0.57 dividend. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.00%. STERIS's dividend payout ratio (DPR) is presently 48.41%.
About STERIS
(
Free Report)
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
See Also
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider STERIS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.
While STERIS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
